Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders...
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will...
Founding directors Daniel F. Sansone and Jean S. Blackwell to conclude board service at the 2026 Annual Meeting
Ingevity Corporation (NYSE: NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company...
Ingevity Corporation (NYSE:NGVT) today announced it has been named to Newsweek’s America’s Most Responsible Companies list for the fourth consecutive year. The 2026 award recognizes...
Transaction reduces portfolio volatility, strengthens Ingevity’s margin and cash flow profile and enhances strategic flexibility
Ingevity Corporation (NYSE: NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief...
Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation
CANTON, Mass. , Nov. 11, 2025 /PRNewswire/ -- CHASM Advanced Materials, Inc. (CHASM) announced today the signing by Ingevity Corporation (NYSE: NGVT) of a license agreement for CHASM's patented,...